| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 11/02/2004 | CA2317736C Bisulfate salt of hiv protease inhibitor |
| 11/02/2004 | CA2317131C Novel erythromycin derivatives |
| 10/28/2004 | WO2004092388A1 Vector |
| 10/28/2004 | WO2004092374A1 METHOD OF REGULATING ACTIVATION OF TRANSCRIPTIONAL FACTORS NF-AT, AP-1 AND NF-κB USING EFFECT OF ACTIVATING ADAPTOR PROTEIN 3BP2 |
| 10/28/2004 | WO2004092373A1 Peptide having htlv-1-specific ctl-inducing activity |
| 10/28/2004 | WO2004092209A2 S. pneumoniae antigens |
| 10/28/2004 | WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling |
| 10/28/2004 | WO2004092192A1 Sulfoglycolipid antigens, their extraction from mycobacterium tuberculosis, and their use against tuberculosis |
| 10/28/2004 | WO2004092169A1 Spiropiperidine compound and medicinal use thereof |
| 10/28/2004 | WO2004092139A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 10/28/2004 | WO2004092136A1 Nitrogenous heterocyclic compound and use thereof |
| 10/28/2004 | WO2004092128A1 Anhydrous crystalline forms of (2s, 4s)-1-{(2r)-2-amino-3-‘4-methoxybenzyl)sulfonyl!-3-methylbutanoyl}-4-fluoropyrrolindine-2-carbonitrile |
| 10/28/2004 | WO2004091724A1 Anthranilic acid derivatives useful in treating infection with hepatitis c virus |
| 10/28/2004 | WO2004091666A1 Compositions containing piperacillin and tazobactam useful for injection |
| 10/28/2004 | WO2004091653A1 Interferon beta in severe acute respiratory syndrome (sars) |
| 10/28/2004 | WO2004091652A1 Pharmaceutical composition containing interferon for the treatment of hpv infections |
| 10/28/2004 | WO2004091640A1 Skin protecting compositions |
| 10/28/2004 | WO2004091638A1 Herbal composition |
| 10/28/2004 | WO2004091637A2 System capable of treating and defining various diseases using stem cells |
| 10/28/2004 | WO2004091611A1 Carbonic anhydrase inhibitors to eradicate helicobacter pylori |
| 10/28/2004 | WO2004073596A3 Vaccine composition comprising an hiv proteic antigen incorporated into multilamellar lipidic vesicles |
| 10/28/2004 | WO2004055041A3 Defensin-inducing peptides from fusobacterium |
| 10/28/2004 | WO2004047925A3 Therapeutic oxidation catalysts |
| 10/28/2004 | WO2004000228A3 Methods for preventing and treating microbial infections by modulating transcription factors |
| 10/28/2004 | WO2003104262A3 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells |
| 10/28/2004 | WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 10/28/2004 | WO2003089573A3 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 10/28/2004 | WO2003087126A3 Heteroclitic analogs and related methods |
| 10/28/2004 | WO2003077840A3 Method of modulating inflammatory response |
| 10/28/2004 | WO2003037371A3 Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents |
| 10/28/2004 | WO2001098460A3 Fusion proteins of mycobacterium tuberculosis |
| 10/28/2004 | US20040215017 Such as 2-methylpropyl-(4-bromo-3-fluorophenyl)carbamate |
| 10/28/2004 | US20040214994 Genetically engineered immunoglobulin specific for hepatitis helicase for use in prevention and treatment of infection; immunotherapy |
| 10/28/2004 | US20040214902 Small molecule antagonists of BCL-2 family proteins |
| 10/28/2004 | US20040214897 Uses for 2-amino-2-propane-1,3-diols |
| 10/28/2004 | US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis |
| 10/28/2004 | US20040214864 Novel compounds |
| 10/28/2004 | US20040214848 Concurrent administration of microbiocide and opiate inhibitors of transport proteins; drug screening |
| 10/28/2004 | US20040214844 N4-acylcytosine nucleosides for treatment of viral infections |
| 10/28/2004 | US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer |
| 10/28/2004 | US20040214834 Pyrazolo-pyridines for the treatment of herpes infections |
| 10/28/2004 | US20040214814 Pyrazole compounds useful as protein kinase inhibitors |
| 10/28/2004 | US20040214801 9-Substituted minocycline compounds |
| 10/28/2004 | US20040214792 Methods of treating inflammation |
| 10/28/2004 | US20040214784 covalent conjugates with mono-, di- , poly- or thiaalkanoic acids; ability to adjust the solubility of steroidal molecules, lipophilicity and bioavailability by altering the structure and length of the acid chain; avoids or reduces the local irritation caused by the parent drug |
| 10/28/2004 | US20040214759 Compositions and methods of use for a fibroblast growth factor |
| 10/28/2004 | US20040214756 administering mixtures of antithrombin and interleukins, tumor necrosis factors or enzyme inhibitors, for prophylaxis of infections |
| 10/28/2004 | US20040214331 Transforming and propagating viral-like particle in cells; for use as tools in prevention and treatment of viral infection; viricides and genetic vaccines |
| 10/28/2004 | US20040214304 Microbiocidal gastrointestinal microorganism for use in food processing and the prevention of infection; bacteriocin |
| 10/28/2004 | US20040214251 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay |
| 10/28/2004 | US20040214229 Amino acid sequences for use in diagnosis, prevention and treatment of sepsis and infections |
| 10/28/2004 | US20040214165 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 10/28/2004 | US20040213834 Pharmacological preparation made from a nanopatriculate mesomorphous polyelectrolyte lipid complex and at least one active ingredient |
| 10/28/2004 | US20040213804 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide |
| 10/28/2004 | US20040213802 Gene of novel corynebacterium diphtheriae antigen |
| 10/28/2004 | US20040213799 Boosting priming composition with nonreplicating and/or replication impaired strains of poxvirus vectors; forming human immunodeficiency virus inhibitors |
| 10/28/2004 | US20040213797 Conjugates for the modulation of immune responses |
| 10/28/2004 | US20040213772 Peptide factor |
| 10/28/2004 | CA2562789A1 Herbal composition |
| 10/28/2004 | CA2548643A1 System capable of treating and defining various diseases using stem cells |
| 10/28/2004 | CA2522238A1 S. pneumoniae antigens |
| 10/28/2004 | CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling |
| 10/28/2004 | CA2522007A1 Methods of preventing or treating respiratory conditions |
| 10/28/2004 | CA2521972A1 Skin protection composition comprising an extract of sasa |
| 10/28/2004 | CA2521826A1 Recombinant il-9 antibodies and uses thereof |
| 10/28/2004 | CA2521809A1 Improved heat shock protein-based vaccines and immunotherapies |
| 10/28/2004 | CA2521650A1 Interferon beta in severe acute respiratory syndrome (sars) |
| 10/27/2004 | EP1471147A2 Method of making a recombinant molecule for the expression of HPV-16 L1 protein |
| 10/27/2004 | EP1471141A1 Method for the production of resveratrol in cell cultures |
| 10/27/2004 | EP1471074A2 Methods for improving the conformation of proteins by means of reducing agents |
| 10/27/2004 | EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 10/27/2004 | EP1470825A1 Reagents for detecting efavirenz |
| 10/27/2004 | EP1470257A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470256A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE /GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470249A2 Effectors of innate immunity |
| 10/27/2004 | EP1470237A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 10/27/2004 | EP1470223A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 10/27/2004 | EP1470218A2 Corona-virus-like particles comprising functionally deleted genomes |
| 10/27/2004 | EP1470160A2 Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection |
| 10/27/2004 | EP1470159A2 Antibody to latent membrane proteins and uses thereof |
| 10/27/2004 | EP1470154A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 10/27/2004 | EP1470148A2 Double-stranded oligonucleotides |
| 10/27/2004 | EP1470144A2 Oligonucleotides comprising alternating segments and uses thereof |
| 10/27/2004 | EP1470138A1 Mmp inhibitors |
| 10/27/2004 | EP1470137A1 Edg receptor agonists |
| 10/27/2004 | EP1470131A2 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| 10/27/2004 | EP1470125A1 Aminopiperidine derivatives |
| 10/27/2004 | EP1470124A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES |
| 10/27/2004 | EP1470123A1 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, related compositions and methods |
| 10/27/2004 | EP1470119A1 Benzothiophene compounds having antiinfective activity |
| 10/27/2004 | EP1470113A1 Pyrimidinone viral polymerase inhibitors |
| 10/27/2004 | EP1470112A1 Substituted pyridazinones as inhibitors of p38 |
| 10/27/2004 | EP1470104A2 Novel compounds that inhibit factor xa activity |
| 10/27/2004 | EP1469888A2 Stem cell screening and transplantation therapy for hiv infection |
| 10/27/2004 | EP1469882A2 Treatment of ms with goat serum |
| 10/27/2004 | EP1469880A2 Method for reducing morbidity and mortality in critically ill patients |
| 10/27/2004 | EP1469876A2 Antimicrobial cationic peptides and formulations thereof |
| 10/27/2004 | EP1469866A1 Cycloglycans suitable to inhibit mammalian infection |
| 10/27/2004 | EP1469857A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis |
| 10/27/2004 | EP1469854A1 Condensed heterocyclic compounds |